GTDRIVES: Dynamic Dialogues - W.E.B. Du Bois: Agent of Change - His Relevance Today, Part 1

Nikki Lewis Simon, a commercial litigator with more than two decades of experience, primarily serves as the firm’s Chief Diversity, Equity & Inclusion Officer. In this capacity, Nikki designs and guides strategic initiatives and programs to deepen firmwide diversity and inclusion efforts that further enrich client engagements and community investments. Her role is indicative of, and integral to, Greenberg Traurig’s core values of collaboration and inclusion – principles that inform the firm’s operations and legal business in meaningful, positive ways. Prior to assuming primary responsibilities on the business side of the firm, Nikki has represented her cross-industry clients’ business objectives by protecting their capital – human, intellectual, and financial – against claims of wrongdoing in complex commercial and class action litigation. Those matters have spanned the panoply of issues and claims businesses often face, from discrimination to wrongful death, defamation to fraud and misrepresentation, professional negligence and malpractice to breach of fiduciary duty and securities law violations.

David Dykeman, who serves as Co-Managing Shareholder of Greenberg Traurig's Boston office and co-chairs the firm's global Life Sciences & Medical Technology Group, is a registered patent attorney with 25 years of experience in patent and intellectual property law. David's practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities. An author of over 55 articles and a speaker at over 50 conferences on intellectual property law, David is the founding co-chair of the ABA’s Medical Devices Committee. In 2022, LMG Life Sciences named him the Patent Strategy Attorney of the Year for Massachusetts. He was honored as one of Boston's "40 Under 40" innovative business leaders by the Boston Business Journal and was named to the "40 Medtech Innovators Under 40" list by Medical Device & Diagnostic Industry (MD+DI) Magazine. David has also been named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine, an "IP Star" by Managing IP magazine, a "Life Science Star" by LMG Life Sciences, one of the World's Leading IP Strategists in the IAM 300, and ranked in Chambers. Concentrations Intellectual property Patent prosecution and opinions Licensing IP due diligence Trademarks and unfair competition Copyrights